Mayne Pharma Group Ltd
ASX:MYX
Mayne Pharma Group Ltd
ASX:MYX
Price:
2.35
AUD
-2.49%
Market Closed
Market Cap:
AU$190.9m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Mayne Pharma Group Ltd
ASX:MYX
|
AU |
|
IAR Systems Group AB
F:NC91
|
SE |
Price Target
Loading...
Revenue
Loading...
Gross Profit
Loading...
Operating Income
Loading...
Pre-Tax Income
Loading...
Net Income
Loading...
Wall St Price Targets
MYX Price Targets Summary
Mayne Pharma Group Ltd
Mayne Pharma Group Ltd
Wall Street analysts forecast MYX stock price to rise over the next 12 months.
According to Wall Street analysts, the average 1-year price target for MYX is 6.22 AUD with a low forecast of 6.16 AUD and a high forecast of 6.41 AUD.
Lowest Forecast
Price Target
6.16
AUD
162% Upside
Average Forecast
Price Target
6.22
AUD
165% Upside
Highest Forecast
Price Target
6.41
AUD
173% Upside
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is MYX's stock price target?
Price Target
6.22
AUD
6.22
AUD
According to Wall Street analysts, the average 1-year price target for MYX is 6.22 AUD with a low forecast of 6.16 AUD and a high forecast of 6.41 AUD.
What is the Revenue forecast for Mayne Pharma Group Ltd?
Projected CAGR
1%
1%
Over the last 7 years, the compound annual growth rate for Revenue has been -4%. The projected CAGR for the next 3 years is 1%.
